Taiwan · Delayed Price · Currency is TWD Jia Jie Biomedical Statistics
Total Valuation
TPEX:4109 has a market cap or net worth of TWD 1.36 billion. The enterprise value is 963.19 million.
| Market Cap | 1.36B |
| Enterprise Value | 963.19M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4109 has 118.74 million shares outstanding. The number of shares has increased by 16.94% in one year.
| Current Share Class | 118.74M |
| Shares Outstanding | 118.74M |
| Shares Change (YoY) | +16.94% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | n/a |
| Float | 92.64M |
Valuation Ratios
The trailing PE ratio is 24.69.
| PE Ratio | 24.69 |
| Forward PE | n/a |
| PS Ratio | 2.79 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 63.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 86.18, with an EV/FCF ratio of -14.81.
| EV / Earnings | 17.45 |
| EV / Sales | 1.98 |
| EV / EBITDA | 86.18 |
| EV / EBIT | n/a |
| EV / FCF | -14.81 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.08 |
| Quick Ratio | 3.76 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 6.89 |
| Debt / FCF | -1.18 |
| Interest Coverage | -12.27 |
Financial Efficiency
Return on equity (ROE) is 3.34% and return on invested capital (ROIC) is -0.55%.
| Return on Equity (ROE) | 3.34% |
| Return on Assets (ROA) | -0.24% |
| Return on Invested Capital (ROIC) | -0.55% |
| Return on Capital Employed (ROCE) | -0.41% |
| Weighted Average Cost of Capital (WACC) | 3.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.26 |
| Inventory Turnover | 12.66 |
Taxes
In the past 12 months, TPEX:4109 has paid 1.83 million in taxes.
| Income Tax | 1.83M |
| Effective Tax Rate | 3.16% |
Stock Price Statistics
The stock price has decreased by -31.85% in the last 52 weeks. The beta is -0.03, so TPEX:4109's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -31.85% |
| 50-Day Moving Average | 11.94 |
| 200-Day Moving Average | 14.52 |
| Relative Strength Index (RSI) | 47.19 |
| Average Volume (20 Days) | 238,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4109 had revenue of TWD 487.66 million and earned 55.20 million in profits. Earnings per share was 0.46.
| Revenue | 487.66M |
| Gross Profit | 140.72M |
| Operating Income | -7.28M |
| Pretax Income | 58.12M |
| Net Income | 55.20M |
| EBITDA | 8.54M |
| EBIT | -7.28M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 503.65 million in cash and 76.97 million in debt, with a net cash position of 426.68 million or 3.59 per share.
| Cash & Cash Equivalents | 503.65M |
| Total Debt | 76.97M |
| Net Cash | 426.68M |
| Net Cash Per Share | 3.59 |
| Equity (Book Value) | 1.70B |
| Book Value Per Share | 14.07 |
| Working Capital | 450.33M |
Cash Flow
In the last 12 months, operating cash flow was 21.36 million and capital expenditures -86.39 million, giving a free cash flow of -65.03 million.
| Operating Cash Flow | 21.36M |
| Capital Expenditures | -86.39M |
| Depreciation & Amortization | 15.81M |
| Net Borrowing | 67.39M |
| Free Cash Flow | -65.03M |
| FCF Per Share | -0.55 |
Margins
Gross margin is 28.86%, with operating and profit margins of -1.49% and 11.32%.
| Gross Margin | 28.86% |
| Operating Margin | -1.49% |
| Pretax Margin | 11.92% |
| Profit Margin | 11.32% |
| EBITDA Margin | 1.75% |
| EBIT Margin | -1.49% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 107.54% |
| Buyback Yield | -16.94% |
| Shareholder Yield | -15.20% |
| Earnings Yield | 4.06% |
| FCF Yield | -4.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2019. It was a reverse split with a ratio of 0.8487883546.
| Last Split Date | Mar 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.8487883546 |
Scores
TPEX:4109 has an Altman Z-Score of 5.84 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.84 |
| Piotroski F-Score | 3 |